Coping with continual danger: Assessing alertness to visual disturbances in crucian carp following long-term exposure to chemical alarm signals

2014 ◽  
Vol 126 ◽  
pp. 50-56
Author(s):  
Monika M. Durajczyk ◽  
Ole B. Stabell
Keyword(s):  
Crucian Carp ◽  
Alarm Signals ◽  
Chemical Alarm Signals ◽  
Visual Disturbances

Intraspecific and Cross-Superorder Responses to Chemical Alarm Signals by Brook Stickleback

Ecology ◽  
1993 ◽  
Vol 74 (8) ◽  
pp. 2395-2404 ◽  
Author(s):  
Alicia Mathis ◽  
R. Jan F. Smith
Keyword(s):  
Alarm Signals ◽  
Chemical Alarm Signals ◽  
Brook Stickleback

scholarly journals Endocrine aspects and sequel in patients with craniopharyngioma

2015 ◽  
Vol 28 (1-2) ◽  
Author(s):  
Eva Marie Erfurth
Keyword(s):  
Bone Health ◽  
Neurological Deficits ◽  
Pituitary Tumours ◽  
Cranial Radiotherapy ◽  
Parasellar Region ◽  
Hypothalamic Damage ◽  
Visual Disturbances ◽  
Overall Mortality

AbstractA craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5–2.0 cases/million per year and approximately 60% of CP is seen in adulthood. The therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. Typical initial manifestations at diagnosis in children are symptoms of elevated intracranial pressure, visual disturbances and hypopituitarism. CPs have the highest mortality of all pituitary tumours. The standardised overall mortality rate varies from 2.88 to 9.28 in cohort studies. Adults with CP have a 3–19-fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health and reduction in quality of life and cognitive function.

ADVERSE DRUG REACTION OF LITHIUM CARBONATE-A REVIEW

2016 ◽  
Vol 4 (1) ◽  
pp. 1
Author(s):  
Bhausaheb B. Jankar ◽  
Devesh D. Gosavi
Keyword(s):  
Beta Blockers ◽  
Safety Monitoring ◽  
Lithium Carbonate ◽  
Lithium Therapy ◽  
Therapeutic Drug ◽  
Duration Of Therapy ◽  
Level Increase ◽  
Gi Symptoms ◽  
Visual Disturbances

This study aims to review Lithium-associated ADRs during the treatment and its management. Databases of "Medline", "Google Scholar" and "PubMed" were searched with keywords for studies on ADRs of Lithium. All studies involving safety, monitoring and management of adverse drug reactions of Lithium were included. Most of the studies have reported that up to 50 to 80% of patients develop ADRs on Lithium. Common initial ADRs that develops within 1 w to 6 w are polydipsia and polyuria taken together (50 to 70%) followed by tremors (30 to 60%). GI symptoms (upset, abdominal pain and diarrhoea) up to 30% are other commoner ADRs of Lithium therapy and they mostly disappear later. Weight gain (20 to 50%), Hypothyroidism (14-34%) and Nephrotic diabetes insipidus develop during the long term Lithium therapy. Most of the ADRs are produced even at therapeutic range (0.6–1.2 mEq/l). As serum level increase, i.e. above 1.5 mEq/l, other serious ADRs like muscle fasciculation’s, worsening of tremor, dysarthria, ataxia, EPS, hallucination, and visual disturbances, seizures, coma, and death may be expected. Management of ADRs includes TDM, Dose reduction of Lithium, drugs like diuretics, beta blockers, SR preparations and sometimes withdrawal of the drug. We are concluded that Lithium can cause many ADRs depending upon dose and duration of therapy, hence, the Therapeutic Drug Monitoring of Lithium is necessary.

Effects and bioaccumulation of 17β-estradiol and 17α-ethynylestradiol following long-term exposure in crucian carp

2015 ◽  
Vol 112 ◽  
pp. 169-176 ◽  
Author(s):  
Bin Huang ◽  
Wenwen Sun ◽  
Xiaoman Li ◽  
Jingliang Liu ◽  
Qiang Li ◽  
...  
Keyword(s):  
Crucian Carp ◽  
17Β Estradiol
Sign in / Sign up

Export Citation Format

Share Document